SCHEDULE 13D

Company

Estrella Immunopharma, Inc.

Filed

October 30, 2023

Accession Number

0001013762-23-007392

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →